Literature DB >> 31327316

Thrombolytic Therapy for Acute Ischemic Stroke.

Patrick D Lyden1.   

Abstract

Entities:  

Keywords:  clinical trial; headache; humans; thrombectomy; tissue-type plasminogen activator

Year:  2019        PMID： 31327316      PMCID： PMC6710099          DOI： 10.1161/STROKEAHA.119.025699

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  79 in total

1.  ANTICOAGULANTS PLUS STREPTOKINASE THERAPY IN PROGRESSIVE STROKE.

Authors:  J S MEYER; J GILROY; M I BARNHART; J F JOHNSON
Journal:  JAMA       Date:  1964-08-03       Impact factor: 56.272

2.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

3.  Comparison of TNK with wild-type tissue plasminogen activator in a rabbit embolic stroke model.

Authors:  D F Chapman; P Lyden; P A Lapchak; S Nunez; H Thibodeaux; J Zivin
Journal:  Stroke       Date:  2001-03       Impact factor: 7.914

4.  Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. NINDS; The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.

Authors: 
Journal:  Stroke       Date:  2000-12       Impact factor: 7.914

5.  Thrombolysis in patients with transient neurologic deficits.

Authors:  P Lyden; M Lu; T Kwiatkowski; M Frankel; S Levine; J Broderick; T Brott
Journal:  Neurology       Date:  2001-12-11       Impact factor: 9.910

6.  Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.

Authors:  T G Kwiatkowski; R B Libman; M Frankel; B C Tilley; L B Morgenstern; M Lu; J P Broderick; C A Lewandowski; J R Marler; S R Levine; T Brott
Journal:  N Engl J Med       Date:  1999-06-10       Impact factor: 91.245

7.  Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia.

Authors:  J Astrup; L Symon; N M Branston; N A Lassen
Journal:  Stroke       Date:  1977 Jan-Feb       Impact factor: 7.914

Review 8.  Thrombolysis, stroke units and other strategies for reducing acute stroke costs.

Authors:  T H Wein; S L Hickenbottom; A V Alexandrov
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981

9.  Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study.

Authors:  J R Marler; B C Tilley; M Lu; T G Brott; P C Lyden; J C Grotta; J P Broderick; S R Levine; M P Frankel; S H Horowitz; E C Haley; C A Lewandowski; T P Kwiatkowski
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

10.  Cost-Utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke: a Canadian healthcare perspective.

Authors:  S E Sinclair; L Frighetto; P S Loewen; R Sunderji; P Teal; S C Fagan; C A Marra
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981
View more
  2 in total

1.  Ensemble learning accurately predicts the potential benefits of thrombolytic therapy in acute ischemic stroke.

Authors:  Zhihong Chen; Qingqing Li; Renyuan Li; Han Zhao; Zhaoqing Li; Ying Zhou; Renxiu Bian; Xinyu Jin; Min Lou; Ruiliang Bai
Journal:  Quant Imaging Med Surg       Date:  2021-09

2.  Network Pharmacology and Bioinformatics Methods Reveal the Mechanism of Berberine in the Treatment of Ischaemic Stroke.

Authors:  Ke Song; Yikun Sun; Haoqi Liu; Yuanyuan Li; Na An; Liqin Wang; Hanlai Zhang; Fan Yang; Yanwei Xing; Yonghong Gao
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-29       Impact factor: 2.650
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.